
ENHA Stock Forecast & Price Target
ENHA Analyst Ratings
Bulls say
Enhanced Group is well positioned because its Live Enhanced platform combines subscription revenue, clinician-guided Rx protocols, OTC supplements, and personalization into a recurring consumer relationship that can deepen retention and expand average spend. Its moat is reinforced by the Enhanced Games, which reached 1B people globally, generated $32M in sponsorship value, and drove nearly half of Live Enhanced’s customers, creating a proprietary marketing and data flywheel that should lower CAC versus ad-dependent peers. Fundamental upside is also supported by scale potential, with management and research pointing to about $271M-$272M of 2028 revenue and 132% 2026-2028E revenue CAGR, while the $50M PIPE and expected profitability in 2027 improve funding visibility.
Bears say
Enhanced Group is a high-risk, early-stage company with a going-concern profile, having incurred losses since founding and operating with only limited liquidity from a $20M working capital note and about $3M from SPAC redemptions. Its core businesses are untested, beginning with $0 revenue earlier this year, and face substantial uncertainty from competitive pressure, brand-trust and ethics concerns around performance-enhancing substances, and regulatory changes that could either raise compliance costs or restrict sales. The outlook is further weakened by likely shareholder dilution from options, warrants, and future financing, alongside majority voting control by Apeiron and the co-founders, which limits governance protections for minority investors.
This aggregate rating is based on analysts' research of Enhanced Group Inc and is not a guaranteed prediction by Public.com or investment advice.
ENHA Analyst Forecast & Price Prediction
Start investing in ENHA
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Enhanced Group Inc (ENHA) Forecast
ENHA Analyst Forecast & Price Prediction
Start investing in ENHA
Order type
Buy in
Order amount
Est. shares
0 shares